Isolated blast crisis in CNS in a patient with chronic myelogenous leukemia maintaining major cytogenetic response after imatinib.
Kim
Hyun Jung
HJ
Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Jung
Chul Won
CW
Kim
Kihyun
K
Ahn
Jin Seok
JS
Kim
Won Seog
WS
Park
Kwan
K
Ko
Young Hye
YH
Kang
Won Ki
WK
Park
Keunchil
K
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001549:Benzamides; D001752:Blast Crisis / Q000209:etiology* / Q000473:pathology; D002531:Cerebellum / Q000473:pathology*; D004334:Drug Administration Schedule; D017809:Fatal Outcome; D006801:Humans; D000068877:Imatinib Mesylate; D017404:In Situ Hybridization, Fluorescence; D007278:Injections, Spinal; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D008297:Male; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate